This tendency to the higher TGF-β1 and HGF plasma levels in the IBD patients is consistent with the current view that both cytokines exert aggressive effects on pathophysiology events of ulcerative colitis and that TGF-β might be the major cytokine during times of active inflammation. This evidence concerns the gene HGF and ulcerative colitis.